← Back to Search

Behavioral Intervention

Behavioral Intervention for Postpartum Care

N/A
Waitlist Available
Led By Mark A Clapp, MD, MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months after the patient's estimated date of delivery
Awards & highlights

Study Summary

This trial will test if a behavioral science-informed intervention, incorporating defaults and salience, can increase the rates of PCP follow-up within 4 months following a delivery for individual with hypertension, diabetes, obesity.

Who is the study for?
This trial is for pregnant individuals or those within 2 weeks post-delivery, aged 18+, with access to an EHR patient portal. They must have a primary care provider and conditions like high blood pressure, diabetes, obesity, depression/anxiety. It's not for those without a PCP in the EHR or who don't speak English/Spanish.Check my eligibility
What is being tested?
The study tests if setting default appointments, targeted messages, and nudge reminders can increase primary care visits after delivery among patients with hypertension or diabetes. This randomized trial aims to improve long-term health by encouraging early preventative care.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience increased communication from healthcare providers which could affect their daily routine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months after the patient's estimated date of delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months after the patient's estimated date of delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Rate of antidepressant use among individuals with mood or anxiety disorders
Rate of antihypertensive use among individuals with hypertension
Rate of assessment of glycemic control among individuals with or at risk for diabetes
+14 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Facilitated TransitionExperimental Treatment3 Interventions
Behavioral science informed interventions to assist in the transition from postpartum to primary care providers
Group II: ControlActive Control1 Intervention
Routine postpartum care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Targeted messaging
2012
N/A
~450

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,197,945 Total Patients Enrolled
33 Trials studying Hypertension
124,983 Patients Enrolled for Hypertension
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,016,703 Total Patients Enrolled
41 Trials studying Hypertension
1,229,831 Patients Enrolled for Hypertension
National Bureau of Economic Research, Inc.OTHER
31 Previous Clinical Trials
922,880 Total Patients Enrolled
1 Trials studying Hypertension
74 Patients Enrolled for Hypertension

Media Library

Behavioral Science-Informed Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05543265 — N/A
Hypertension Research Study Groups: Facilitated Transition, Control
Hypertension Clinical Trial 2023: Behavioral Science-Informed Intervention Highlights & Side Effects. Trial Name: NCT05543265 — N/A
Behavioral Science-Informed Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05543265 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study actively searching for participants?

"As indicated on clinicaltrials.gov, the trial is still open and accepting participants. It was first published on November 3rd 2022 with its latest update being made that same day."

Answered by AI

What is the current patient enrollment rate for this clinical trial?

"Confirmed. The information by clinicaltrials.gov indicates that this medical study, posted on November 3rd 2022 and up-to-date as of the same day, is actively looking for 350 participants from a single location."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Bridging the Gap From Postpartum to Primary Care
Mark Clapp, MD MPH 2022. "Bridging the Gap From Postpartum to Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05543265.
All > Anxiety Disorder
~149 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top